Advertisement

International Journal of Clinical Pharmacy

, Volume 39, Issue 4, pp 686–696 | Cite as

Contributions of community pharmacists to patients on antidepressants—a qualitative study among key informants

  • Laurence Guillaumie
  • Jocelyne Moisan
  • Jean-Pierre Grégoire
  • Denis Villeneuve
  • Clément Beaucage
  • Lilianne Bordeleau
  • Sophie LauzierEmail author
Research Article

Abstract

Background Patients with an antidepressant drug treatment (ADT) report unmet needs and a significant proportion stop their ADT prematurely. Community pharmacists can play a key role in supporting these patients. Objective To explore the perspectives of various leaders in health care about the current and potential contributions of community pharmacists to patients on ADT. Setting The province of Quebec (Canada). Method We conducted a qualitative descriptive exploratory study using interviews among leaders who were involved in health care services, pharmaceutical services, physician and pharmacist education, as well as patient and healthcare professional associations. Verbatim transcripts of interviews were analyzed using computer-assisted thematic analysis. Main outcome measure Perspectives about the contributions of community pharmacists to patients on ADT. Results Interviews revealed that pharmacists are perceived to be accessible drug experts whose particular strengths are their thorough knowledge of drugs, their commitment to ensure ADT safety and tolerability, as well as their commitment to inform and support patients. Leaders trained in pharmacy or representatives of pharmacy organizations had concrete expectations for pharmacists’ increased involvement in monitoring ADT adherence and efficacy. They extensively discussed the regulatory and organizational changes required to enhance this role. Leaders also stated that, in addition to patients, health care teams could benefit from pharmacists’ expertise and support. Conclusion Participating key informants perceived the need for enhanced pharmacist monitoring of ADT adherence and efficacy. They also expressed their openness to an increased collaboration between health care teams and pharmacists.

Keywords

Antidepressant agents Canada Community pharmacy services Interviews Key informants Medication therapy management Qualitative study 

Notes

Funding

Unrestricted Grant from the Prends soin de toi program (AstraZeneca, Lilly, Lundbeck and Merck). L. Guillaumie received a post-doctoral research scholarship from the Chair on adherence to treatments. The Chair on Adherence to Treatments is funded through unrestricted Grants from AstraZeneca Canada, Merck Canada, Pfizer Canada, Sanofi Canada and the Prends soin de toi program S. Lauzier is a research scholar from the Fonds de recherche du QuébecSanté in partnership with the Institut national d’excellence en santé et en services sociaux.

Conflicts of interest

D. V. is president of Panacée Conseil providing professional development services to pharmacists. Other authors have no conflicts to declare.

References

  1. 1.
    Patten SB, Kennedy SH, Lam RW, O'Donnovan C, Filteau MJ, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults I. Classification, burden and principles of management. J Affect Disord. 2009;117(Suppl 1):S5–14.Google Scholar
  2. 2.
    Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand. 2002;105(3):164–72.CrossRefPubMedGoogle Scholar
  3. 3.
    Olfson M, Marcus SC, Tedeschi M, Wan GJ. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry. 2006;163:101–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Hodgkin D, Volpe-Vartanian J, Alegria M. Discontinuation of antidepressant medication among Latinos in the USA. J Behav Health Serv Res. 2007;34:329–42.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Buus N, Johannessen H, Stage KB. Explanatory models of depression and treatment adherence to antidepressant medication: a qualitative interview study. Int J Nurs Stud. 2012;49:1220–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Friedman SJ, Meyers BS. Stigma as a barrier to recovery: perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv. 2001;52:1615–20.CrossRefPubMedGoogle Scholar
  7. 7.
    Thompson L, McCabe R. The effect of clinician-patient alliance and communication on treatment adherence in mental health care: a systematic review. BMC Psychiatry. 2012;12:87.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Bull SA, Hu XH, Hunkeler EM, Lee JY, Ming EE, Markson LE, et al. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA. 2002;288:1403–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Mitchell AJ. Depressed patients and treatment adherence. Lancet. 2006;367:2041–3.CrossRefPubMedGoogle Scholar
  10. 10.
    Garfield S, Francis S-A, Smith FJ. Building concordant relationships with patients starting antidepressant medication. Patient Educ Couns. 2004;55:241–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Tibaldi G, Salvador-Carulla L, Garcia-Gutierrez JC. From treatment adherence to advanced shared decision making: new professional strategies and attitudes in mental health care. Curr Clin Pharmacol. 2011;6:91–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Adams JR, Drake RE, Wolford GL. Shared decision-making preferences of people with severe mental illness. Psychiatr Serv. 2007;58(9):1219–21.CrossRefPubMedGoogle Scholar
  13. 13.
    Maidment R, Livingston G, Katona C. ‘Just keep taking the tablets’: adherence to antidepressant treatment in older people in primary care. Int J Geriatr Psychiatry. 2002;17:752–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Swanson KA, Bastani R, Rubenstein LV, Meredith LS, Ford DE. Effect of mental health care and shared decision making on patient satisfaction in a community sample of patients with depression. Med Care Res Rev. 2007;64:416–30.CrossRefPubMedGoogle Scholar
  15. 15.
    Phokeo V, Sproule B, Raman-Wilms L. Community pharmacists’ attitudes toward and professional interactions with users of psychiatric medication. Psychiatr Serv. 2004;55:1434–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Liekens S, Smits T, Laekeman G, Foulon V. Pharmaceutical care for people with depression: Belgian pharmacists’ attitudes and perceived barriers. Int J Clin Pharm. 2012;34:452–9.Google Scholar
  17. 17.
    Scheerder G, De Coster I, Van Audenhove C. Pharmacists’ role in depression care: a survey of attitudes, current practices, and barriers. Psychiatr Serv. 2008;59:1155–60.CrossRefPubMedGoogle Scholar
  18. 18.
    Chong WW, Aslani P, Chen TF. Pharmacist–patient communication on use of antidepressants: a simulated patient study in community pharmacy. RSAP. 2014;10:419–37.PubMedGoogle Scholar
  19. 19.
    Guillaumie L, Moisan J, Grégoire J-P, Villeneuve D, Beaucage C, Bujold M, et al. Perspective of community pharmacists on their practice with patients who have an antidepressant drug treatment: findings from a focus group study. RSAP. 2015;11:e43–56.PubMedGoogle Scholar
  20. 20.
    Gardner DM, Murphy AL, Woodman AK, Connelly S. Community pharmacy services for antidepressant users. Int J Pharm Pract. 2001;9:217–24.CrossRefGoogle Scholar
  21. 21.
    Cannon-Breland ML, Westrick SC, Kavookjian J, Berger BA, Shannon DM, Lorenz RA. Pharmacist self-reported antidepressant medication counseling. J Am Pharm Assoc. 2012;53:390–9.CrossRefGoogle Scholar
  22. 22.
    Chong WW, Aslani P, Chen TF. Adherence to antidepressant medications: an evaluation of community pharmacists’ counseling practices. Patient Prefer Adherence. 2013;7:813–25.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Marshall MN. The key informant technique. Fam Pract. 1996;13(1):92–7.CrossRefPubMedGoogle Scholar
  24. 24.
    Miles MB, Huberman AM, Saldaña J. Qualitative data analysis: a methods sourcebook. Thousand Oaks: SAGE Publications, Inc; 2013.Google Scholar
  25. 25.
    Creswell JW. Research design: qualitative, quantitative, and mixed methods approaches. Thousand Oaks: SAGE publications, Inc; 2013.Google Scholar
  26. 26.
    Burgess RG. In the field: an introduction to field research. Abingdon: Routledge; 2002.Google Scholar
  27. 27.
    Saldaña J. The coding manual for qualitative researchers. Thousand Oaks: SAGE Publications, Inc; 2009.Google Scholar
  28. 28.
    Paillé P, Mucchielli A. L’analyse qualitative en sciences humaines et sociales. 2nd ed. Paris: Armand Colin; 2003.Google Scholar
  29. 29.
    Tarn DM, Paterniti DA, Wenger NS, Williams BR, Chewning BA. Older patient, physician and pharmacist perspectives about community pharmacists’ roles. Int J Pharm Pract. 2012;20(5):285–93.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Bradshaw SJ, Doucette WR. Community pharmacists as patient advocates: physician attitudes. J Am Pharm Assoc. 1997;38(5):598–602.CrossRefGoogle Scholar
  31. 31.
    Howard M, Trim K, Woodward C, Dolovich L, Sellors C, Kaczorowski J, et al. Collaboration between community pharmacists and family physicians: lessons learned from the Seniors Medication Assessment Research Trial. J Am Pharm Assoc. 2002;43(5):566–72.CrossRefGoogle Scholar
  32. 32.
    Edmunds J, Calnan MW. The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and General Practioners in the United Kingdom. Soc Sci Med. 2001;53(7):943–55.CrossRefPubMedGoogle Scholar
  33. 33.
    Hughes CM, McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract. 2003;53(493):600–6.PubMedPubMedCentralGoogle Scholar
  34. 34.
    Ordre des pharmaciens du Québec. Standards de pratique. Montréal: Direction des servies professionnels, Ordre des pharmaciens du Québec; 2010.Google Scholar
  35. 35.
    Pottie K, Farrell B, Haydt S, Dolovich L, Sellors C, Kennie N, et al. Integrating pharmacists into family practice teams: physicians’ perspectives on collaborative care. Can Fam Physician. 2008;54(12):1714–1717.e5.PubMedPubMedCentralGoogle Scholar
  36. 36.
    Smith M, Cannon-Breland ML, Spiggle S. Consumer, physician, and payer perspectives on primary care medication management services with a shared resource pharmacists network. RSAP. 2014;10(3):539–53.PubMedGoogle Scholar
  37. 37.
    Loi sur la pharmacie. Gouvernement du Québec. 2015. http://www2.publicationsduquebec.gouv.qc.ca/dynamicSearch/telecharge.php?type=2&file=/P_10/P10.HTM. Accessed 26 May 2016.
  38. 38.
    Surveillance de la thérapie médicamenteuse. Lignes directrices. Ordre des pharmaciens du Québec. http://www.opq.org/cms/Media/807_38_fr-CA_0_ld_surveillance_therapie_med.pdf. Accessed 02 July 2014.
  39. 39.
    Guide de pratique 1-Fournir des soins pharmaceutiques. Ordre des pharmaciens du Québec. http://guide.opq.org/1_Role_03.html. Accessed 02 July 2014.
  40. 40.
    Grainger-Rousseau TJ, Miralles MA, Hepler CD, Segal R, Doty RE, Ben-Joseph R. Therapeutic outcomes monitoring: application of pharmaceutical care guidelines to community pharmacy. J Am Pharm Assoc (Wash). 1997;NS37(6):647–61.CrossRefGoogle Scholar
  41. 41.
    Francke A, Smit M, de Veer A, Mistiaen P. Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Mak. 2008;8(1):38.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Practice change in community pharmacy: quantification of facilitators. Annals Pharmacother. 2008;42(6):861–8.CrossRefGoogle Scholar
  43. 43.
    Tsuyuki RT, Schindel TJ. Changing pharmacy practice: the leadership challenge. Can Pharm J. 2008;141(3):174–80.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Chair on Adherence to TreatmentsUniversité LavalQuébecCanada
  2. 2.Population Health and Optimal Health Practices Unit, Centre de recherche du CHU de Québec-Université LavalHôpital du Saint-SacrementQuébecCanada
  3. 3.Faculty of NursingUniversité LavalQuébecCanada
  4. 4.Faculty of PharmacyUniversité LavalQuébecCanada
  5. 5.Panacée ConseilQuébecCanada
  6. 6.Direction régionale de la santé publiqueAgence de la santé et des services sociaux de la Capitale-NationaleQuébecCanada

Personalised recommendations